Selling to Health Systems: How Enterprise Healthcare Deals Actually Get Done

Sarah Kerns
Jul 2
2 min read

Selling to health systems is not a longer version of selling to everyone else. It is a different discipline. The companies that win enterprise healthcare deals treat it that way. The ones that stall keep running a mid-market playbook against a buyer that does not respond to it.

After 25 years selling into health systems, here is what actually determines whether an enterprise deal closes.

The buying committee is the deal

No health system deal has one buyer. A typical enterprise agreement touches clinical leadership, IT, finance, compliance, and operations before it reaches a signature. Each function can say no. Almost none of them can say yes alone.

Map the committee before you invest in the deal. If your team cannot name the CFO's likely objection, the IT security review process, and the clinical champion's success metric by the second meeting, you are not in an enterprise sales process. You are in a series of demos.

Budget cycles decide timing, not your quarter

Health systems plan budgets annually, and most operating budgets lock months before the fiscal year starts. If your deal is not in the budget conversation early enough, the most enthusiastic champion in the world cannot fund it this year.

This is why enterprise healthcare pipelines look wrong to leaders who came from other industries. The deals are real. The timing is structural. Build your forecast around the buyer's fiscal calendar and your pipeline reviews stop being fiction.

Your champion needs a business case, not a brochure

Your champion spends most of the sales cycle selling internally, without you in the room. What you arm them with is what the deal becomes.

Give them a one-page business case in the health system's own language: the operational problem, the cost of the status quo, the expected impact in dollars or hours, the implementation lift, and the risk story. If your champion has to build that themselves, the deal slows to the pace of their spare time.

Pilots stall without a contracted expansion path

Health systems love pilots. Pilots without predefined success criteria and a contracted expansion path are where enterprise deals go to die. A pilot should specify what will be measured, who judges success, and what happens commercially when the criteria are met. Negotiate the expansion before the pilot starts, while you still have leverage.

Procurement is a stage, not an afterthought

Security review, legal, and procurement can add months to a signed-in-spirit deal. Treat them as a formal pipeline stage with owners and dates. Ask about the vendor review process in the first month, not after verbal agreement. The best enterprise sellers start the paperwork while the committee is still deciding.

What this means for your team

Enterprise health system sales rewards structure. Committee maps, fiscal calendars, champion enablement, pilot-to-contract design, and procurement management are not administrative overhead. They are the sale.

If your team is working hard and enterprise deals are still slipping, the problem is usually the system around the sellers, not the sellers. That is fixable, and it is exactly the work we do at Harborline.